A Novo executive noted that many customers are unaware that the company already makes oral semaglutide for type 2 diabetes ...

Novo Nordisk (NVO) on Wednesday announced plans to launch some doses of its oral GLP-1 receptor agonist semaglutide under the ...

Novo Nordisk said on Wednesday it will launch some doses of its oral semaglutide for diabetes under the brand name Ozempic ...

The Apple iPad mini A17 Pro is excellent for reading, thanks to its compact, lightweight, and easy-to-hold design. Not only is the 8.3-inch Liquid Retina screen vibrant, sharp, and colorful, making ...

TONMYA demonstrated significant reduction in fibromyalgia pain compared with placebo in the Phase 3 RESILIENT study Unique sublingual formulation designed for bedtime dosing bypasses first-pass ...

NVO and VKTX face rising competition and setbacks as investors weigh scale, pipelines and execution risks in the crowded ...

India and the European Union have reached a free trade agreement that covers up to 2 billion people after nearly two decades ...

Significant Order with New International Pharmaceutical Customer Highlights Company's Growth and Revenue Opportunity ORLANDO, FLORIDA / ACCESS Newswire / January 22, 2026 / Laser Photonics Corporation ...

Significant Order with New International Pharmaceutical Customer Highlights Company's Growth and Revenue Opportunity ORLANDO, FLORIDA / ACCESS Newswire / January 22, 2026 / Laser Photonics Corporation ...

Prakhar Khanna is a Writer at CNET with bylines in ZDNET, Forbes, and other major outlets. A digital nomad at heart, he thrives in chaos--mixing deadlines with travel, often writing stories on planes, ...

I Departamento de Ciências Farmacêuticas, Universidade Federal de Santa Catarina, Campus Universitário Trindade, Bl. K, 88040-900, Florianópolis - SC, Brasil II Departamento de Ciências Farmacêuticas, ...